OBTAIN HIGH

Strategic Update: New Leadership and Market Compliance

Obtain High is under new ownership. The original developer and owner has stepped down to pursue external career opportunities that are incompatible with association with this industry. This transition was executed as a private, internal transfer between two parties with thoroughly vetted ethical backgrounds. We are fully committed to upholding the rigorous quality control, transparency, and professional service established by our predecessor. Our dedication to providing lab-tested, medical-grade products remains absolute.

As part of our ongoing commitment to regulatory compliance and operational risk management, we are implementing an immediate suspension of all shipments to Sweden.

While our logistical infrastructure successfully achieved a 99% delivery success rate to the region, we ultimately encountered persistent and insurmountable interventions by local authorities that disrupted the final delivery phase. Maintaining our operational standards requires a reliable jurisdictional environment. Because these local actions made it impossible to guarantee seamless, compliant service, we must withdraw from the market.

We take immense pride in supplying rigorously tested, organic, medical-grade cannabis formulations designed with consumer safety as the priority. Unfortunately, the current regulatory landscape in Sweden actively obstructs these premium, lab-verified products, ultimately funneling consumers toward unregulated, synthetic alternatives that lack necessary safety oversight. As a company built on scientific precision and harm reduction, we cannot align our operations with an environment that systematically rejects verified organic products in favor of untested substances.

Effective immediately, there will be no shipping to Sweden until further notice.

We will continue to serve our compliant global markets with the same discretion, safety protocols, and premium quality you expect. Thank you for your continued trust in Obtain High.